Skip to main content

Mubadala — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

101
Companies
$15.7B
Total invested
$308.0M
Avg. check
51
Industries
Biotechnology 8FinTech 6Health Care 6Software 4Financial Services 4Medical 3+45 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 7396 of 101
Light Horse Therapeutics
January 2025

Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.

Biotechnology · San Diego$62.0M Series A
Tenvie Therapeutics
January 2025

Tenvie Therapeutics is a biotechnology company that transforms the treatment of neurological diseases through engineered small molecules.

Biotechnology · South San Francisco$200.0M Series A
HiveMQ
January 2025

HiveMQ is the proven enterprise MQTT platform designed to connect, communicate, and control IoT data under real-world stress.

Enterprise Software · LandshutSeries Unknown
nChroma Bio
December 2024

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

Biotechnology · Boston$75.0M Series Unknown
Zelis
December 2024

Zelis is modernizing the healthcare financial experience for all.

Finance · BedminsterPrivate Equity
9fin
December 2024

9fin is an AI-powered analytics platform designed for credit analysis and mandate acquisition.

Analytics · London$50.0M Series B
GC Therapeutics
September 2024

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Biotechnology · Boston$65.0M Series A
Outpace Bio
August 2024

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Biotechnology · Seattle$144.0M Series B
Telegram
March 2024

Telegram is a cloud-based mobile and desktop messaging tool that provides privacy, security, and speed.

Information Services · Dubai$330.0M Debt Financing
Andalusia Labs
December 2023

Andalusia Labs is an applied research lab building internet-native economic infrastructure.

Artificial Intelligence (AI) · Palo Alto$48.0M Series A
Coin Metrics
October 2023

Coin Metrics is a provider of crypto financial intelligence providing network data, market data, index, and network risk solutions.

Analytics · Boston$6.7M Series Unknown
Centenara Labs
September 2023

Centenara Labs is an integrated biotechnology platform company that invests in people and ideas to develop therapies.

Biotechnology · SchlierenDebt Financing
Hasten
April 2023

Hasten is a pharmaceutical manufacturing company that integrates R&D, manufacturing, and commercialization.

Health Care · Hefei$315.0M Series Unknown
JD Industry
March 2023

JD Industry specializes in industrial maintenance, repair, and operations (MRO).

B2B · Beijing$300.0M Series B
Ignis Therapeutics
January 2023

Ignis Therapeutics is a innovative therapies in the field of central nervous system.

Biotechnology · Shanghai$2.8M Series A
UpStream Care
December 2022

UpStream Care is the ideal marketplace solution for medicine.

Health Care · Greensboro$140.0M Series B
SK biopharmaceuticals
November 2022

Specialty Pharmaceutical Company

Biotechnology · SeongnamGrant
Nebula Brands
July 2022

Nebula is a tech-driven firm with expertise in M&A, online retail, eCommerce, branding, and local supply chain management.

E-Commerce · BeijingSeries B
Weavr
February 2022

Weavr is an online platform that creates, integrates, deploys, and runs digital payment flows.

Developer Platform · London$40.0M Series A
Virtuoso
November 2021

Virtuoso is a software development company that develops codeless test automation software.

Information Services · London$13.3M Series A
Halo Investing
October 2021

Halo Investing is a financial technology platform that provides structured note investments to the average investor.

Finance · Chicago$100.0M Series C
Ocrolus
September 2021

Ocrolus is an AI-powered data and analytics platform that enables faster and more accurate financial decision-making.

Artificial Intelligence (AI) · New York$80.0M Series C
Borzo
August 2021

Borzo is a global logistic same-day delivery marketplace.

Courier Service · Mumbai$35.0M Series C
Sarwa
July 2021

Sarwa is a financial platform and app that lets you easily trade stocks and ETFs, save and invest your money passively all in one place.

FinTech · Dubai$15.0M Series B

Where Mubadala invests

Biotechnology8
FinTech6
Health Care6
Software4
Financial Services4
Medical3

About Mubadala's portfolio

How many companies has Mubadala invested in?

Mubadala has invested in 101 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Mubadala invest in?

Mubadala's top investment sectors include Biotechnology, FinTech, Health Care, Software, Financial Services. The firm invests across 51 different industry categories.

What is Mubadala's largest investment?

Among tracked funding rounds, Telegram received $330.0M in a Debt Financing round. Mubadala's total known invested capital is $15.7B.

What is the average investment size for Mubadala?

Mubadala's average investment size is $308.0M across its portfolio of 101 companies.

What are Mubadala's most recent investments?

Recent Mubadala portfolio additions include Light Horse Therapeutics, Tenvie Therapeutics, HiveMQ, nChroma Bio, Zelis. These companies were founded in 2020 or later.

Reach the founders behind these 101 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →